gw0742
GW0742 attenuates hepatic endoplasmic
Avis client GW0742 is a potent PPARβ and PPARδ agonist, with an IC50 of 1 nM for human PPARδ, and EC50s of 1 nM, μM and 2 μM for human PPARδ, PPARα, and
เว็บไซต์ gw0742 Avis client GW0742 is a potent PPARβ and PPARδ agonist, with an IC50 of 1 nM for human PPARδ, and EC50s of 1 nM, μM and 2 μM for human PPARδ, PPARα, and gw0742 GW0742 controls Type 1 Diabetes in rats Studies have shown that GW0742 has off target, non- PPARβδ effects in the cell although there are
gw0742 Taken together, our results clearly show that GW0742 reduces the lung injury and inflammation due to the intratracheal BLEO-instillation in mice References GW0742 is known to be an activator of PPAR-δ,19 and it can increase the expression of PPAR-δ 20 Therefore, GW0742 is widely used as an agonist GW0742 is a selective agonist of PPARδ with EC50 value of nM Important Notice: For research use only We do not sell to patients * Please check COA
ไม่สามารถโหลดการรับสินค้าได้ ความพร้อมใช้งาน
